⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BMRN News
BioMarin Pharmaceuticals Inc
Form 8-K
sec.gov
BMRN
BioMarin Announces Close of the Alesta Therapeutics Acquisition
prnewswire.com
BMRN
Ascendis and BioMarin Enter Binding Term Sheet for a Global Settlement and License Agreement Related to YUVIWEL® (Navepegritide)
globenewswire.com
ASND
BMRN
Form 8-K
sec.gov
BMRN
BioMarin Announces Global Settlement with Ascendis Pharma A/S; Ascendis Will Pay Royalties to BioMarin on Yuviwel Sales in U.S., EU, Brazil and South Korea
prnewswire.com
BMRN
Rare Disease Treatment (2026-2031) - Expanding Orphan Drug Development Drives Market Growth
globenewswire.com
JNJ
AMGN
PFE
BMY
VRTX
BMRN
ULTA
REGN
SRPT
HRZN
PTC
Global Pediatric Drugs (2026-2031) - Rising Prevalence of Childhood Diseases Drives Market Growth
globenewswire.com
PFE
JNJ
GSK
SNY
NVS
PTC
BMRN
JAZZ
GILD
LLY
AMGN
AZN
MRK
ABBV
TAK
Form 8-K
sec.gov
BMRN
BioMarin to Acquire Alesta Therapeutics to Gain ALE1, a Potential First Oral Therapy for Hypophosphatasia, Adding an Important Clinical Program to BioMarin's Pipeline
prnewswire.com
BMRN
Gene Therapy Remains Top-of-Mind in Hemophilia Despite Recent Market Contraction, as Physicians and Patients Raise the Bar for Success
globenewswire.com
PFE
BMRN
CSL